NPX-887

N/A

Report date: 2024/02/06 20:00:33

Base Information

Drug NameNPX-887
Drug Alias NameNPX887NPX-887
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-HERV-H LTR-associating protein 2
TargetsHERV-H LTR-associating protein 2
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNextPoint Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextPoint Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A